Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin vs Vancomycin for Newborn Sepsis
NCT01867138Phase 3Completed
- Sponsor
- Hospital Italiano de Buenos Aires
- Start
- Mar 2007
- Primary completion
- Aug 2010
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 3, randomised trial of cefazolin in neonatal sepsis (2 arms), sponsored by Hospital Italiano de Buenos Aires. Primary endpoint: Clinical outcome of infants. Started Mar 2007; status: completed.
02
Drugs
cefazolin
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on NCT01867138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01867138.